Skip to main content
. 2024 Jul 26;10(15):e35228. doi: 10.1016/j.heliyon.2024.e35228

Fig. 6.

Fig. 6

Relationship between risk score and drug efficacy in patients with gastric cancer. (A) Violin plot of differences in immune markers in high and low-risk scores. (B) Relationship between TIDE score and risk score. (C–J) Relationship between risk score and chemotherapeutic drug sensitivity. *, P < 0.05. **, P < 0.01. ***, P < 0.001.